Tutorials
NAS:TRIB (Ireland)  
Trinity Biotech PLC logo

Trinity Biotech PLC

$ 1.41 +0.03 (+2.17%) 08:09 PM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 53.73M
Enterprise V:
$ 119.03M
Volume:
34.04K
Avg Vol (2M):
50.59K
Also Trade In:
Volume:
34.04K
Market Cap $:
53.73M
PE Ratio:
At Loss
Avg Vol (2-Month):
50.59K
Enterprise Value $:
119.03M
PB Ratio:
0
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Trinity Biotech PLC
NAICS : 325413 SIC : 2835
IDA Business Park, Bray, Co. Wicklow, Dublin, IRL
Description
Trinity Biotech PLC is in the business of development, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point of care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Premier, Immublot, EZ, Capita, and others. Geographically, it has two segments namely the Americas, and Ireland of which it derives a majority of its revenues from the Americas segment.
Name Current Vs Industry Vs History
Cash-To-Debt 0.13
Equity-to-Asset -0.06
Debt-to-Equity -12.17
Debt-to-EBITDA 23.14
Interest Coverage 1.64
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.68
Distress
Grey
Safe
Beneish M-Score -2.87
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
3-Year Revenue Growth Rate -2.4
Name Current Vs Industry Vs History
5-Day RSI 61.15
9-Day RSI 58.71
14-Day RSI 57.01
6-1 Month Momentum % 20.8
12-1 Month Momentum % -39.87

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.66
Quick Ratio 1.8
Cash Ratio 0.63
Days Inventory 230.31
Days Sales Outstanding 65.44
Days Payable 131.15

Dividend & Buy Back

Name Current Vs Industry Vs History

Financials (Next Earnings Date:2022-09-09 Est.)

TRIB's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:TRIB

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 86.147
EPS (TTM) ($) -0.545
Beta 1.28
Volatility % 52.97
14-Day RSI 57.01
14-Day ATR ($) 0.082297
20-Day SMA ($) 1.356635
12-1 Month Momentum % -39.87
52-Week Range ($) 0.86 - 3.05
Shares Outstanding (Mil) 38.11

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Trinity Biotech PLC Filings

Document Form Filing Date
No Filing Data

Headlines

See More